{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:02:18Z","timestamp":1764403338652,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ajg.2023.12.006","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T14:20:26Z","timestamp":1708352426000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Raghda N.","family":"Marzaban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham I.","family":"AlMekhzangy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-2230","authenticated-orcid":false,"given":"Wafaa","family":"ElAkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer M","family":"ElBaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehia M.","family":"ElShazly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadry","family":"ElSaeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Anees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy A.","family":"ElSerafy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal G.","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahid H.","family":"Doss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajg.2023.12.006_b0005","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/diacare.27.5.1171","article-title":"High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury","volume":"27","author":"Lecube","year":"2004","journal-title":"Diabetes Care American Diabetes Association"},{"issue":"14","key":"10.1016\/j.ajg.2023.12.006_b0010","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3748\/wjg.v18.i14.1642","article-title":"Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis","volume":"18","author":"Naing","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"s2","key":"10.1016\/j.ajg.2023.12.006_b0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2036.2005.02598.x","article-title":"Review article: an unexpected virus-host interaction - the hepatitis C virus-diabetes link","volume":"22","author":"Ratzu","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"9973","key":"10.1016\/j.ajg.2023.12.006_b0020","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","article-title":"Hepatitis C","volume":"385","author":"Webster","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajg.2023.12.006_b0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/COH.0b013e32834b87f8","article-title":"Future of hepatitis C therapy","volume":"6","author":"Dore","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"issue":"9","key":"10.1016\/j.ajg.2023.12.006_b0030","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc17-0485","article-title":"Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus","volume":"40","author":"Hum","year":"2017","journal-title":"Diabetes Care American Diabetes Association"},{"key":"10.1016\/j.ajg.2023.12.006_b0035","doi-asserted-by":"crossref","unstructured":"Pavone P, Tieghi T, D\u2019Ettorre G, Lichtner M, Marocco R, Mezzaroma I, et al. Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents. Clin Microbiol Infect. 2016 May;22(5):462.e1-462.e3.","DOI":"10.1016\/j.cmi.2015.12.030"},{"key":"10.1016\/j.ajg.2023.12.006_b0040","series-title":"The Liver and Portal Hypertension","first-page":"50","article-title":"Surgery and portal hypertension","author":"Child","year":"1964"},{"issue":"2","key":"10.1016\/j.ajg.2023.12.006_b0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.ajg.2023.12.006_b0050","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ajg.2023.12.006_b0055","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ajg.2023.12.006_b0060","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ajg.2023.12.006_b0065","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1464-5491.1995.tb00432.x","article-title":"Diabetes mellitus in Egypt: risk factors and prevalence","volume":"12","author":"Herman","year":"1995","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.ajg.2023.12.006_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-8-367","article-title":"Association of HCV with diabetes mellitus: an Egyptian case-control study","volume":"8","author":"Elhawary","year":"2011","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.ajg.2023.12.006_b0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2023.12.006_b0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11892-004-0023-7","article-title":"Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights","volume":"4","author":"Bahtiyar","year":"2004","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.ajg.2023.12.006_b0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1440-1746.2008.05503.x","article-title":"Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection","volume":"24","author":"Chehadeh","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2023.12.006_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s005350300063","article-title":"Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus","volume":"38","author":"Arao","year":"2003","journal-title":"J Gastroenterol"},{"issue":"27","key":"10.1016\/j.ajg.2023.12.006_b0095","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3748\/wjg.v16.i27.3427","article-title":"Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection","volume":"16","author":"Rouabhia","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.ajg.2023.12.006_b0100","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.1998.00688.x","article-title":"HCV and diabetes mellitus: evidence for a negative association","volume":"93","author":"Mangia","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajg.2023.12.006_b0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11894-004-0022-5","article-title":"Fat, diabetes, and liver injury in chronic hepatitis C","volume":"6","author":"Ratziu","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.ajg.2023.12.006_b0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00042737-200603000-00011","article-title":"Resolution of diabetes in type 2 diabetic patient treated with IFN-alpha and ribavirin for hepatitis C","volume":"18","author":"Tahrani","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ajg.2023.12.006_b0115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2893.2006.00729.x","article-title":"Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C","volume":"13","author":"Greenberg","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ajg.2023.12.006_b0120","doi-asserted-by":"crossref","unstructured":"The EA for the S of Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018;1\u201351.","DOI":"10.30856\/th.jhep2018vol1iss3_13"},{"issue":"s1","key":"10.1016\/j.ajg.2023.12.006_b0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1478-3231.2011.02701.x","article-title":"New targets for antiviral therapy of chronic hepatitis C","volume":"32","author":"B\u00fchler","year":"2012","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.ajg.2023.12.006_b0130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jhep.2017.11.034","article-title":"Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience","volume":"68","author":"Elsharkawy","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2023.12.006_b0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2015.04.023","article-title":"Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4","volume":"63","author":"Doss","year":"2015","journal-title":"J Hepatol Elsevier"},{"issue":"20","key":"10.1016\/j.ajg.2023.12.006_b0140","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med Massachusetts Medical Society"},{"issue":"5","key":"10.1016\/j.ajg.2023.12.006_b0145","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2014.10.044","article-title":"Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry","volume":"62","author":"Ruane","year":"2015","journal-title":"J Hepatol Elsevier"},{"issue":"2","key":"10.1016\/j.ajg.2023.12.006_b0150","doi-asserted-by":"crossref","first-page":"S772","DOI":"10.1016\/S0168-8278(16)01505-1","article-title":"Real-life results of sofosbuvir based therapy for Egyptian Patients with hepatitis C and advanced fibrosis-cirrhosis","volume":"64","author":"Doss","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2023.12.006_b0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12072-018-9861-2","article-title":"Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience","volume":"12","author":"Shiha","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ajg.2023.12.006_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9616234","article-title":"Clinical study sofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a cohort of egyptian patients: an experiment the size of Egyptian Village","volume":"2018","author":"Ahmed","year":"2018","journal-title":"Int J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2023.12.006_b0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/apt.14428","article-title":"Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt","volume":"47","author":"Omar","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2023.12.006_b0170","unstructured":"Shiha G, Waked I, Soliman R, Abdelrazek W, Hassany M, Fouad R, et al. Ledipasvir\/Sofosbuvir in Egyptian Patients With Chronic Genotype 4 HCV Infection. Conference Report for NATAP. In AASLD. Liver meeting. Boston Nov. 2016."},{"issue":"3","key":"10.1016\/j.ajg.2023.12.006_b0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1060028014563952","article-title":"Ledipasvir-Sofosbuvir","volume":"49","author":"Smith","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"9916","key":"10.1016\/j.ajg.2023.12.006_b0180","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(13)62121-2","article-title":"Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial","volume":"383","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajg.2023.12.006_b0185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2008.12.017","article-title":"Insulin resistance predicts response to peginterferon-alpha\/ribavirin combination therapy in chronic hepatitis C patients","volume":"50","author":"Dai","year":"2009","journal-title":"J Hepatol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197923001168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197923001168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T14:04:16Z","timestamp":1717337056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197923001168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1687197923001168"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2023.12.006","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of Pan-Arab Association of Gastroenterology.","name":"copyright","label":"Copyright"}]}}